Starting HIV treatment at a CD4 cell count above 500 reduced the risk of serious illness including tuberculosis (TB), and death, by 44% when compared to starting treatment according to World Health Organization (WHO) guidelines, results from the seven-year Temprano study show. The findings were presented on Wednesday (February 25) at the Conference on Retroviruses and Opportunistic Infections (CROI 2015) in Seattle, USA.
The study also found that a six-month course of isoniazid preventive treatment reduced the risk of developing TB by 35%.
Source: Aidsmap